Cystic Fibrosis Foundation's Net Worth
$11.3 Million
Who is Cystic Fibrosis Foundation?
Cystic Fibrosis Foundation has an estimated net worth of $11.3 Million. This is based on reported shares across multiple companies, which include Aridis Pharmaceuticals, Inc., and BiomX Inc..
SEC CIK
Cystic Fibrosis Foundation's CIK is 0001957515
Past Insider Trading and Trends
2024 was Cystic Fibrosis Foundation's most active year for acquiring shares with 1 total transactions. Cystic Fibrosis Foundation's most active month to acquire stocks was the month of April. 2024 was Cystic Fibrosis Foundation's most active year for disposing of shares, totalling 1 transactions. Cystic Fibrosis Foundation's most active month to dispose stocks was the month of April. 2024 saw Cystic Fibrosis Foundation paying a total of $4,778.27 for 4,778,265 shares, this is the most they've acquired in one year. In 2024 Cystic Fibrosis Foundation cashed out on 4,778,265 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aridis Pharmaceuticals, Inc. (ARDS) Snapshot price: $0.064
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BiomX Inc. (PHGE) Snapshot price: $1.2094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +104.96% | 4.78M |
—
| $4,778.27 | 9.33M |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||